Establishment Labs Holdings (ESTA) Operating Expenses (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Operating Expenses came in at $48.8 million in Q1 2026, up 9.14% year-on-year from $44.8 million in Q1 2025, and down 1.25% quarter-over-quarter from $49.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Operating Expenses (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Operating Expenses history runs 10 years deep, the most recent figure standing at $48.8 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 9.14% year-over-year to $48.8 million in Q1 2026; TTM through Mar 2026 was $189.4 million, a 10.73% increase from a year earlier, with the FY2025 full-year figure at $185.3 million, up 16.18% from the prior year.
- Operating Expenses retreated to $48.8 million in Q1 2026 per ESTA's latest filing, from $49.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $49.5 million in Q4 2025 and bottomed at $30.5 million in Q1 2022.
- The 5-year median for Operating Expenses is $41.7 million (2025), against an average of $41.9 million.
- Across the five-year window, Operating Expenses jumped 45.05% in 2022 and retreated 17.49% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $41.3 million in 2022, then climbed by 3.33% to $42.7 million in 2023, then advanced by 15.13% to $49.2 million in 2024, then increased by 0.61% to $49.5 million in 2025, then slipped by 1.25% to $48.8 million in 2026.
- Per Business Quant, the three latest ESTA Operating Expenses figures stand at $48.8 million (Q1 2026), $49.5 million (Q4 2025), and $41.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 785.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 495.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -668.50 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -47.00 Mn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 48.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.85 Mn |
| Dec 31, 2025 | 49.46 Mn |
| Sep 30, 2025 | 41.72 Mn |
| Jun 30, 2025 | 49.38 Mn |
| Mar 31, 2025 | 44.75 Mn |
| Dec 31, 2024 | 49.16 Mn |
| Sep 30, 2024 | 38.86 Mn |
| Jun 30, 2024 | 38.28 Mn |
| Mar 31, 2024 | 33.21 Mn |
| Dec 31, 2023 | 42.70 Mn |
| Sep 30, 2023 | 47.09 Mn |
| Jun 30, 2023 | 43.97 Mn |
| Mar 31, 2023 | 38.24 Mn |
| Dec 31, 2022 | 41.33 Mn |
| Sep 30, 2022 | 36.56 Mn |
| Jun 30, 2022 | 37.86 Mn |
| Mar 31, 2022 | 30.51 Mn |
| Dec 31, 2021 | 33.59 Mn |
| Sep 30, 2021 | 28.66 Mn |
| Jun 30, 2021 | 26.10 Mn |